
Sign up to save your podcasts
Or


This program will discuss Type 1 Diabetes. This lecture reviews epidemiology of diabetes, with focus on type 1 diabetes mellitus (T1D) as well as the care of patients with T1D in pregnancy. The first half of the talk will focus on global epidemiology and highlight the prevalence of T1D in adults. The presenter will discuss why identification of T1D is important and how to prevent progression through the stages. The second half of the talk will focus on pregnancy including the targets for care during pregnancy and the impacts of glucose control in range.
Diabetes prevalence is growing globally. Management of glycemia during pregnancy is complicating and dynamic. Glucose targets are as close to normal as possible while minimizing hypoglycemia. Many women become pregnant are already using automated insulin delivery systems that are not FDA approved for use in pregnancy given the lack of pregnancy-specific glucose targets. Counseling women on off-label use of automated insulin delivery systems in pregnancy is necessary, and many times, the automated activity needs to be turned off to meet glycemic targets. Continuous glucose monitoring has shown many benefits for mother and neonate.
Link to transcript
[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/04/Type1Diabetes_transcript.pdf)
By The Ohio State University Wexner Medical Center5
55 ratings
This program will discuss Type 1 Diabetes. This lecture reviews epidemiology of diabetes, with focus on type 1 diabetes mellitus (T1D) as well as the care of patients with T1D in pregnancy. The first half of the talk will focus on global epidemiology and highlight the prevalence of T1D in adults. The presenter will discuss why identification of T1D is important and how to prevent progression through the stages. The second half of the talk will focus on pregnancy including the targets for care during pregnancy and the impacts of glucose control in range.
Diabetes prevalence is growing globally. Management of glycemia during pregnancy is complicating and dynamic. Glucose targets are as close to normal as possible while minimizing hypoglycemia. Many women become pregnant are already using automated insulin delivery systems that are not FDA approved for use in pregnancy given the lack of pregnancy-specific glucose targets. Counseling women on off-label use of automated insulin delivery systems in pregnancy is necessary, and many times, the automated activity needs to be turned off to meet glycemic targets. Continuous glucose monitoring has shown many benefits for mother and neonate.
Link to transcript
[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/04/Type1Diabetes_transcript.pdf)

32,246 Listeners

134 Listeners

504 Listeners

298 Listeners

3,374 Listeners

113,121 Listeners

56,944 Listeners

5 Listeners

1,150 Listeners

296 Listeners

194 Listeners

367 Listeners

14 Listeners

17 Listeners

2,030 Listeners

14 Listeners

18 Listeners

1 Listeners

1 Listeners

12 Listeners

64 Listeners

0 Listeners

0 Listeners

10 Listeners

3 Listeners

8 Listeners

0 Listeners

8 Listeners

7 Listeners

7 Listeners

5 Listeners

9 Listeners